Cite
MLA Citation
Thomas Cluzeau et al.. “Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).” Journal of clinical oncology, vol. 39, no. 14, 2021, pp. 1575–1583. http://access.bl.uk/ark:/81055/vdc_100150609718.0x000049